| P2093 | author name string | Sang-Ho Jo | |
| P2860 | cites work | Prophylaxis strategies for contrast-induced nephropathy | Q28247353 |
| | Clinical practice. Preventing nephropathy induced by contrast medium | Q28293740 |
| | Potential deleterious effect of furosemide in radiocontrast nephropathy | Q28342922 |
| | A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity | Q33305487 |
| | Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy | Q33320267 |
| | Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia | Q33766645 |
| | Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine | Q33910096 |
| | The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable | Q33975349 |
| | Guidelines on myocardial revascularization | Q34134730 |
| | Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). | Q34209991 |
| | Hospital-acquired renal insufficiency | Q34522737 |
| | N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. | Q34542789 |
| | N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis | Q34722709 |
| | N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. | Q35673022 |
| | Systematic review of the impact of N-acetylcysteine on contrast nephropathy | Q35746654 |
| | N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo | Q35764027 |
| | Contrast-induced nephropathy: a clinical and evidence-based approach | Q36445067 |
| | Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography | Q37991688 |
| | Contrast agents and renal cell apoptosis | Q39983835 |
| | Contrast-medium-induced acute renal failure | Q41695442 |
| | Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study | Q42278871 |
| | Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The L | Q43064442 |
| | High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. | Q43287852 |
| | Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals | Q43465299 |
| | Clinical epidemiology of cardiovascular disease in chronic renal disease | Q43631482 |
| | Acetylcysteine for prevention of contrast nephropathy: meta-analysis | Q43799903 |
| | Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty | Q43873696 |
| | Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention | Q43993720 |
| | A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. | Q44221325 |
| | Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon | Q44252640 |
| | Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency | Q44439737 |
| | Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial | Q44643934 |
| | Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction | Q44668975 |
| | Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity | Q44769664 |
| | Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial | Q44901172 |
| | Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. | Q45209748 |
| | Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome | Q46070961 |
| | N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial | Q46105947 |
| | N-Acetylcysteine does not artifactually lower plasma creatinine concentration | Q46803388 |
| | Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery | Q48670677 |
| | Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion | Q48844001 |
| | Impact of short-duration administration of N-acetylcysteine, probucol and ascorbic acid on contrast-induced cytotoxicity. | Q53250909 |
| | I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. | Q53467325 |
| | Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. | Q53589461 |
| | Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. | Q54107713 |
| | Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock. | Q54187945 |
| | Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. | Q55068250 |
| | Comparison of toxicity of radiocontrast agents to renal tubule cells in vitro | Q68597217 |
| | Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker | Q68854971 |
| | The metabolism of N-acetylcysteine by human endothelial cells | Q70227965 |
| | Acute renal failure | Q71567208 |
| | N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects | Q71807474 |
| | Paracetamol (acetaminophen) poisoning | Q72020055 |
| | Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents | Q72827801 |
| | Prevention of nephrotoxicity induced by radiocontrast agents | Q72827820 |
| | Contrast nephrotoxicity | Q72891519 |
| | Oxidant mechanisms in toxic acute renal failure | Q73091080 |
| | N-acetyl cysteine ameliorates ischemic renal failure | Q73191515 |
| | The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography | Q73218047 |
| | Contrast nephropathy | Q73315375 |
| | Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality | Q73892882 |
| | Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion | Q74642429 |
| | Oxygen free radicals and contrast nephropathy | Q74788096 |
| | A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation | Q78108694 |
| | Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies | Q79798558 |
| | A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media | Q80098929 |
| | Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective cont | Q80843484 |
| | Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? | Q83786878 |
| | Minimizing the renal toxicity of iodinated contrast | Q95381698 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P921 | main subject | acetylcysteine | Q375613 |
| | contrast-induced nephropathy | Q1783300 |
| P304 | page(s) | 695-702 | |
| P577 | publication date | 2011-12-31 | |
| P1433 | published in | Korean circulation journal | Q26842331 |
| P1476 | title | N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review | |
| P478 | volume | 41 | |